Cite
HARVARD Citation
Chalikiopoulou, C. et al. (2016). Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients. Pharmacogenomics. pp. 393-403. [Online].